A single blood test for IgM antibodies to rubella, used to check whether you have had a recent or current infection. It suits anyone who needs their rubella antibody status checked.
1 biomarker as listed by Blue Horizon Medicals.
Rubella IgM is an antibody the body produces during a current or recent rubella infection. Testing for it is one way to check whether you have recently been exposed to or infected with rubella, though the provider notes that a positive result is not always straightforward to interpret unless you also have symptoms or a known history of contact with the virus.
There is no comparison group for this exact test, so it cannot be judged directly against named rivals. Against the wider set of immunity and infection tests we track, though, its £90.25 price sits well below the median of £144.25, a meaningful saving for a single-marker test. Collection is by venous blood draw, either at a clinic or with a nurse home visit, and results are back within 5 days.
The score for this test is helped most by value for money, given how far below the wider market median it is priced, and by clarity, since the listing sets out the description, biomarker, sample type, turnaround and collection options clearly, though it does not describe what the report itself looks like. Results are reviewed by a doctor, which supports the results and follow-up score, and trust signals reflect the provider's Trustpilot record, lab accreditation and years of trading. As a single marker it scores more modestly on clinical depth, and collection convenience is middling because it needs a venous draw rather than an at-home kit, even though a nurse home visit is offered.
This suits you if you want to check your rubella IgM antibody status, for example after a possible exposure, and are comfortable having a venous blood sample taken at a clinic or by a home nurse visit rather than doing an at-home finger-prick kit. Because a positive result on its own is not always easy to interpret, it works best alongside a conversation with a GP about your specific circumstances rather than as a standalone answer. There are no comparable tests in our data for this specific marker, so we cannot point you to a cheaper or deeper alternative here.
You give a blood sample by venous draw, either at a clinic appointment or with a nurse home visit. The sample is sent to the lab for rubella IgM antibody testing, and a doctor reviews the result before it is returned to you. Results are provided within 5 days of your sample being received.
This is a single-marker rubella IgM blood test costing £90.25, well below the £144.25 median we see across similarly sized immunity tests. There are no direct comparison-group peers for this exact test, and the biggest caveat is that a positive IgM result is not always easy to interpret without known exposure or symptoms.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£90.25 against a median of £144.25 for the 79 similarly sized immunity tests we track (-37%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
